Brief: Lucid Diagnostics Provides Business Update And Q4 And Full Year 2022 Financial Results

Lucid Diagnostics

13/03/2023 22:27

March 13 (Reuters) - Lucid Diagnostics Inc  LUCD.O :
    * LUCID DIAGNOSTICS PROVIDES BUSINESS UPDATE AND FOURTH
QUARTER
AND FULL YEAR 2022 FINANCIAL RESULTS
    * : COMPANY SECURES FINANCING OF $24.6 MILLION THROUGH
SEPARATE
OFFERINGS OF PREFERRED STOCK AND DEBT, CONVERTIBLE AFTER
SEPTEMBER 2023
    * : SIGNS IN-NETWORK AGREEMENT WITH LARGEST SECONDARY PPO,
MULTIPLAN, EXPANDING PATIENT ACCESS TO ESOGUARD
    * QTRLY  LOSS PER SHARE $0.29
    * QTRLY ADJUSTED LOSS PER SHARE $0.15
    * Q4 EARNINGS PER SHARE VIEW $-0.38 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn9cyHTDa 
Further company coverage:  LUCD.O 

 ((Reuters.Briefs@thomsonreuters.com;))